Delivering What Matters to Biopharma
With a deep commitment to innovation and patient-centered research, GCP ClinPlus is a proven CRO partner in the neuroscience space.
Our neuroscience team has delivered over 100 studies across indications, including Alzheimer's disease, ALS, ataxia, Parkinson's disease, multiple sclerosis, epilepsy, brain tumors, migraines, and CNS infections.
We offer industry-leading operational models tailored to the unique demands of neurology research, including:
CNS-specific assessment tools (e.g., ADAS-Cog) and CSF biomarker strategies
Flexible, fast-adapting trial designs that overcome placebo effect challenges
Robust data capture and real-time analytics to ensure insight-rich outcomes
Streamlined project timelines, from study start-up to data lock
Dedicated CNS teams offering deep neurological expertise and proactive support
Our CNS trials emphasize scientific precision, patient safety, and global regulatory readiness. Having supported 11 CNS drug approvals—including one for Alzheimer's disease—we're trusted by both global and domestic sponsors to drive neurological innovations forward.
